Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Cancer Discovery · 2026-11-02 · 16 (11) · 2414-2431
DOI: 10.1158/2159-8290.cd-24-1908 ↗Abstract
Abstract Tumor microbes are increasingly recognized for modulating tumor behavior and therapy responses. Intratumoral microbial burden (ITMB) analysis across cancers revealed regulation of immune pathways and activated mast cells, mostly in colorectal and gastric cancers. High-ITMB colorectal cancer leads to interferon (IFN) regulation and is associated with improved outcomes in advanced disease. Single-cell sequencing revealed induction of IFN-related genes (IRG) within microbe-containing human colorectal cancer. Gastrointestinal-luminal mismatch repair–deficient (MMRd) tumors had higher ITMB than proficient tumors. In a rectal MMRd cohort with 100% remission after immune checkpoint blockade (ICB), tumor microbes and microbe-containing mast cells increased. In ICB-sensitive syngeneic murine MMRd tumor models, local tumor microbial depletion impaired ICB efficacy while downregulating IFN signaling. Forced upregulation of IRGs in ADAR1-deficient cancer cells restored immunotherapy responses during microbial ablation. These data highlight dynamic interplay among ITMB, host defense, and immunogenicity, which seems key to determine therapy responses. Significance: The ITMB is linked to transcriptional and immune functional changes that seem to determine tumor sensitivity to immunotherapy. These findings highlight the key role of tumor-resident microbes in shaping the tumor ecosystem, which could be targeted to modulate therapy responses.
EUVIMED